10 20 30 40 50 60 70 80 1AXT - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER IMMUNOGLOBULIN 20-OCT-97 1AXT
TITLE IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH TITLE 2 THE RATES OF NATURAL ENZYMES
COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN IGG2A; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB' FRAGMENT 33F12; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: IMMUNOGLOBULIN IGG2A; COMPND 7 CHAIN: H; COMPND 8 FRAGMENT: FAB' FRAGMENT 33F12
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: BALB/C; SOURCE 6 OTHER_DETAILS: MONOCLONAL ANTIBODY IGG2A FAB' FRAGMENT; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 10 ORGANISM_TAXID: 10090; SOURCE 11 STRAIN: BALB/C; SOURCE 12 OTHER_DETAILS: MONOCLONAL ANTIBODY IGG2A FAB' FRAGMENT
KEYWDS IMMUNOGLOBULIN, ANTIBODY FAB', CATALYST, ALDOLASE REACTION
EXPDTA X-RAY DIFFRACTION
AUTHOR A.HEINE,I.A.WILSON
REVDAT 4 24-FEB-09 1AXT 1 VERSN REVDAT 3 01-APR-03 1AXT 1 JRNL REVDAT 2 18-NOV-98 1AXT 3 SOURCE COMPND REMARK HETATM REVDAT 2 2 3 SEQRES DBREF JRNL KEYWDS REVDAT 1 28-OCT-98 1AXT 0
JRNL AUTH C.F.BARBAS 3RD.,A.HEINE,G.ZHONG,T.HOFFMANN, JRNL AUTH 2 S.GRAMATIKOVA,R.BJORNESTEDT,B.LIST,J.ANDERSON, JRNL AUTH 3 E.A.STURA,I.A.WILSON,R.A.LERNER JRNL TITL IMMUNE VERSUS NATURAL SELECTION: ANTIBODY JRNL TITL 2 ALDOLASES WITH ENZYMIC RATES BUT BROADER SCOPE. JRNL REF SCIENCE V. 278 2085 1997 JRNL REFN ISSN 0036-8075 JRNL PMID 9405338 JRNL DOI 10.1126/SCIENCE.278.5346.2085
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-96 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 CROSS-VALIDATION METHOD : FREE R VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : EVERY 20TH REFLECTION REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.214 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.211 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.317 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1304 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 26080 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.196 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.193 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1127 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 22301 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3350 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 248 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3556.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 3233.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 14365 REMARK 3 NUMBER OF RESTRAINTS : 14062 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.021 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.324 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.088 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.082 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.015 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.068 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE INITIAL REFINEMENT WAS BEGUN REMARK 3 USING X-PLOR. RESIDUES H 128 TO H136 ARE IN WEAK OR NO REMARK 3 ELECTRON DENSITY. THEY WERE REFINED WITH ZERO OCCUPANCY AND REMARK 3 THE LISTED COORDINATES ARE THEREFORE NOT RELIABLE.
REMARK 4 REMARK 4 1AXT COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAY-96 REMARK 200 TEMPERATURE (KELVIN) : 97 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : PT COATED FUSED SILICA X-RAY REMARK 200 MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26432 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 10.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.30200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE, MERLOT REMARK 200 STARTING MODEL: 2CGR REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 18% REMARK 280 PEG 4000, 10% ISOPROPANOL, 100 MM HEPES, PH 7.4.
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.25000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.30000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.65000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.30000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.25000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.65000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 CYS H 128 REMARK 475 GLY H 129 REMARK 475 ASP H 130 REMARK 475 THR H 133 REMARK 475 THR H 134 REMARK 475 GLY H 135 REMARK 475 SER H 136
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C SER H 136 OG SER H 195 1.76 REMARK 500 O SER H 136 OG SER H 195 1.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG L 108 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL L 51 -46.26 76.74 REMARK 500 SER L 67 -177.96 -174.35 REMARK 500 ARG L 155 114.18 -167.97 REMARK 500 ASN L 157 112.16 -166.39 REMARK 500 MET H 18 138.45 -171.63 REMARK 500 ARG H 52 -146.61 -99.62 REMARK 500 VAL H 127 -86.22 -96.24 REMARK 500 THR H 133 27.38 -57.84 REMARK 500 SER H 136 -44.67 115.40 REMARK 500 PHE H 148 139.70 -174.82 REMARK 500 ASP H 183 16.09 59.33 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH H 230 DISTANCE = 5.54 ANGSTROMS
DBREF 1AXT L 3 211 PIR S16112 S16112 3 216 DBREF 1AXT H 114 228 UNP P01865 GCAM_MOUSE 1 100
SEQADV 1AXT TYR L 28 PIR S16112 ASN 33 CONFLICT SEQADV 1AXT PHE L 32 PIR S16112 TYR 37 CONFLICT SEQADV 1AXT ASN L 34 PIR S16112 TYR 39 CONFLICT SEQADV 1AXT SER L 40 PIR S16112 PRO 45 CONFLICT SEQADV 1AXT LEU L 46 PIR S16112 PRO 51 CONFLICT SEQADV 1AXT LYS L 50 PIR S16112 ARG 55 CONFLICT SEQADV 1AXT SER L 89 PIR S16112 PHE 94 CONFLICT SEQADV 1AXT LYS L 103 PIR S16112 ARG 108 CONFLICT
SEQRES 1 L 216 GLU LEU VAL MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 216 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 216 GLN SER LEU VAL HIS SER TYR GLY ASN THR PHE LEU ASN SEQRES 4 L 216 TRP TYR LEU GLN LYS SER GLY GLN SER PRO LYS LEU LEU SEQRES 5 L 216 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 216 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 216 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 216 PHE CYS SER GLN GLY THR HIS VAL PRO TYR THR PHE GLY SEQRES 9 L 216 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 L 216 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 216 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 216 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 216 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 216 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 216 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 216 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 216 PRO ILE VAL LYS SER PHE ASN ARG SEQRES 1 H 218 GLU VAL LYS LEU GLU GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 218 PRO GLY GLY SER MET LYS LEU SER CYS VAL VAL SER GLY SEQRES 3 H 218 LEU THR PHE SER ARG PHE TRP MET SER TRP VAL ARG GLN SEQRES 4 H 218 SER PRO GLU LYS GLY LEU GLU TRP VAL ALA GLU ILE ARG SEQRES 5 H 218 LEU LYS SER ASP ASN TYR ALA THR HIS TYR ALA GLU SER SEQRES 6 H 218 VAL LYS GLY LYS PHE THR ILE SER ARG ASP ASP SER LYS SEQRES 7 H 218 SER ARG LEU TYR LEU GLN MET ASN SER LEU ARG THR GLU SEQRES 8 H 218 ASP THR GLY ILE TYR TYR CYS LYS ILE TYR PHE TYR SER SEQRES 9 H 218 PHE SER TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 H 218 ALA ALA LYS THR THR ALA PRO SER VAL TYR PRO LEU ALA SEQRES 11 H 218 PRO VAL CYS GLY ASP THR THR GLY SER SER VAL THR LEU SEQRES 12 H 218 GLY CYS LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 218 LEU THR TRP ASN SER GLY SER LEU SER SER GLY VAL HIS SEQRES 14 H 218 THR PHE PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SEQRES 15 H 218 SER SER SER VAL THR VAL THR SER SER THR TRP PRO SER SEQRES 16 H 218 GLN SER ILE THR CYS ASN VAL ALA HIS PRO ALA SER SER SEQRES 17 H 218 THR LYS VAL ASP LYS LYS ILE GLU PRO ARG
FORMUL 3 HOH *248(H2 O)
HELIX 1 1 ALA L 80 ASP L 82 5 3 HELIX 2 2 SER L 122 SER L 127 1 6 HELIX 3 3 LYS L 183 ARG L 188 1 6 HELIX 4 4 PHE H 29 ARG H 31 5 3 HELIX 5 5 THR H 84 ASP H 86 5 3 HELIX 6 6 ASN H 162 GLY H 164 5 3 HELIX 7 7 PRO H 213 SER H 215 5 3
SHEET 1 A 4 MET L 4 THR L 7 0 SHEET 2 A 4 ALA L 19 SER L 25 -1 N ARG L 24 O THR L 5 SHEET 3 A 4 ASP L 70 ILE L 75 -1 N ILE L 75 O ALA L 19 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 67 O ASP L 70 SHEET 1 B 5 SER L 10 VAL L 13 0 SHEET 2 B 5 THR L 102 ILE L 106 1 N LYS L 103 O LEU L 11 SHEET 3 B 5 GLY L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 B 5 LEU L 33 GLN L 38 -1 N GLN L 38 O VAL L 85 SHEET 5 B 5 PRO L 44 ILE L 48 -1 N ILE L 48 O TRP L 35 SHEET 1 C 4 THR L 114 PHE L 118 0 SHEET 2 C 4 GLY L 129 ASN L 137 -1 N ASN L 137 O THR L 114 SHEET 3 C 4 MET L 175 THR L 182 -1 N LEU L 181 O ALA L 130 SHEET 4 C 4 VAL L 159 TRP L 163 -1 N SER L 162 O SER L 176 SHEET 1 D 3 ASN L 145 ILE L 150 0 SHEET 2 D 3 SER L 191 THR L 197 -1 N THR L 197 O ASN L 145 SHEET 3 D 3 ILE L 205 ASN L 210 -1 N PHE L 209 O TYR L 192 SHEET 1 E 4 LYS H 3 SER H 7 0 SHEET 2 E 4 MET H 18 SER H 25 -1 N SER H 25 O LYS H 3 SHEET 3 E 4 ARG H 77 MET H 82 -1 N MET H 82 O MET H 18 SHEET 4 E 4 PHE H 67 ASP H 72 -1 N ASP H 72 O ARG H 77 SHEET 1 F 6 GLY H 10 VAL H 12 0 SHEET 2 F 6 THR H 107 VAL H 111 1 N THR H 110 O GLY H 10 SHEET 3 F 6 GLY H 88 TYR H 95 -1 N TYR H 90 O THR H 107 SHEET 4 F 6 TRP H 33 SER H 40 -1 N GLN H 39 O ILE H 89 SHEET 5 F 6 GLY H 44 ILE H 51 -1 N ILE H 51 O MET H 34 SHEET 6 F 6 THR H 57 TYR H 59 -1 N HIS H 58 O GLU H 50 SHEET 1 G 2 LYS H 93 PHE H 96 0 SHEET 2 G 2 PHE H 99 TRP H 103 -1 N TYR H 102 O ILE H 94 SHEET 1 H 4 SER H 120 LEU H 124 0 SHEET 2 H 4 SER H 137 TYR H 147 -1 N LYS H 145 O SER H 120 SHEET 3 H 4 TYR H 185 THR H 194 -1 N VAL H 193 O VAL H 138 SHEET 4 H 4 VAL H 171 PHE H 174 -1 N PHE H 174 O SER H 188 SHEET 1 I 3 THR H 153 TRP H 157 0 SHEET 2 I 3 THR H 206 HIS H 212 -1 N ALA H 211 O THR H 153 SHEET 3 I 3 THR H 217 LYS H 222 -1 N LYS H 221 O CYS H 208 SHEET 1 J 2 VAL H 177 GLN H 179 0 SHEET 2 J 2 LEU H 184 THR H 186 -1 N THR H 186 O VAL H 177
SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.04 SSBOND 3 CYS H 22 CYS H 92 1555 1555 2.06 SSBOND 4 CYS H 142 CYS H 208 1555 1555 2.04
CISPEP 1 THR L 7 PRO L 8 0 0.57 CISPEP 2 VAL L 94 PRO L 95 0 3.98 CISPEP 3 TYR L 140 PRO L 141 0 3.45 CISPEP 4 PHE H 148 PRO H 149 0 -7.33 CISPEP 5 TRP H 199 PRO H 200 0 5.05
CRYST1 56.500 65.300 132.600 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017699 0.000000 0.000000 0.00000
SCALE2 0.000000 0.015314 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007541 0.00000